StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
BMO Capital on Zimmer Biomet (ZBH): 'Sizing ZBH's Japan Iodine-Coated Hip Opportunity'
September 28, 2026 9:30 AM
BMO Capital analyst Vik Chopra reiterated a Market Perform rating and $96.00 price target on Zimmer Biomet (NYSE: ZBH).The analyst ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
